Intersol Solution
Product Images NDC 0942-9602

InterSol Solution is a Platelet Additive Solution with ingredients such as Dibasic Sodium Phosphate, Anhydrous, USP, Monobasic Sodium Phosphate, Monohydrate, USP, Sodium Citrate, Dihydrate, USP, Sodium Acetate, Trihydrate, USP, Sodium Chloride, USP, and Water for Injection, USP quantity sufficient. It is stored at Controlled Room Temperature and should be protected from freezing and excessive heat, and any unused portion should be discarded. The product is not for direct intravenous infusion and should not be used if the package is damaged. For instructions or use, one should strictly follow the information accompanying the product. It is manufactured by Fonwal International Inc. in Marica, Puerto Rico, and has a barcode using Code-128 indicating the lot number and expiration date.*

The text seems to be a collection of symbols with their respective definitions related to a medical product. It includes information regarding sterilization, cautionary notes, lot numbers, expiration dates, and manufacturing details. The product is labeled as fragile, with instructions to handle with care, avoid sharp objects, and not to vent. It is for use in the United States and is subject to federal laws regarding healthcare practitioners.*

Table 1 shows the results of various assessments of leukoreduced platelets that were derived from the AMICUS separator in vitro using InterSol plasma. Parameters such as glucose, lactate, bicarbonate, lactate dehydrogenase, CDE2 expression, morphology score, hypotonic shock response, and extent of shape change were measured over a period of 5 days, with varying mean values and standard deviations.*

This is a table showing the results of various assessments conducted on irradiated and non-irradiated platelets that were derived from a separator and are leukoreduced. The assessments were done in vitro using AMICUS. The table displays results of parameters such as glucose, lactate, PO, Bicarbonate, Lactate Dehydrogenase, CD62 expression, Morphology Score, Hypotonic Shock Response, and Extent of Shape Change. The results are presented as means and standard deviations.*

This is a table showing in vitro assessments of TRIMA ACCEL-derived, leukoreduced platelets. The table displays various parameters such as glucose, lactate, bicarbonate, lactate dehydrogenase, P-selectin, morphology, hypotonic shock response, and extent of shape change. The table shows the mean and standard deviation of these parameters on day 1 and day 5.*